Harald von Boehmer - F1000 Faculty Member (since 04 July 2001)
Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA
BIOGRAPHY
ACADEMIC POSITION:Professor of Microbiology and Immunobiology (MBIB), Harvard Medical School
RESEARCH INTERESTS:
The focus is on T cell development with implications for generation of distinct T cell lineages as well as acute lymphoblastic T cell leukemia (T-ALL). T cell receptor transgenic mice have been utilized to elucidate mechanisms of positive selection that result in the generation of CD8+ killer cells, CD4+ helper cells and CD4+ regulatory cells that express Foxp3. Presently, research focuses on T cell receptor and TGF-beta signaling pathways that permit conversion of naïve T cells into regulatory T cells in vivo and result in antigen-specific tolerance to transplantation antigens. In disease models it was determined that antigen-specific Tregs can suppress tumor-specific immune response by preventing exocytosis of cytolytic granules by CD8 T cells during the effector phase.
Experiments concerned with T cell receptor- and Notch-signaling have revealed that lineage commitment is instructed by the intensity of TCR signals and that Notch signaling is mandatory for the generation of alpha/beta but not gamma/delta lineage cells. Overexpression of intracellular Notch results in T-ALL with highly reproducible phenotypes making it feasible to determine the contribution of oncogenes, tumor suppressors, genomic instability and microRNAs to molecular pathways of malignancy.
EVALUATIONS
Viewing evaluations by Faculty Members requires a subscription.
Sign in | Free Trial | Subscribe
If you believe you should be able to view this content, contact us at info@f1000.com.
